ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
64,027.01
0.21%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Soleno Therapeutics Inc (SLNO)

  7. Soleno Therapeutics Inc (SLNO) Noticias

SLNO Soleno Therapeutics Inc

45.12
-4.11 (-8.35%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Soleno Therapeutics Inc SLNO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-4.11 -8.35% 45.12 17:14:04
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
47.14 44.98 48.49 45.12 49.23
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202421:32GLOBESoleno Therapeutics Announces Pricing of Approximately $138..
02/5/202415:01GLOBESoleno Therapeutics Announces Proposed Public Offering of..
30/4/202407:00GLOBESoleno Therapeutics Announces Peer-Reviewed Publication of..
29/4/202407:00GLOBESoleno Therapeutics Receives Breakthrough Therapy..
19/4/202415:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
08/3/202415:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
07/3/202405:06EDGAR2Form 8-K - Current report
06/3/202415:05GLOBESoleno Therapeutics Provides Corporate Update and Reports..
22/2/202407:00GLOBESoleno Therapeutics to Present at the TD Cowen 44th Annual..
31/1/202415:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/1/202415:57EDGAR2Form 8-K - Current report
29/1/202416:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202416:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202416:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202415:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
24/1/202407:00GLOBESoleno Therapeutics Strengthens Leadership Team with Key..
17/1/202415:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:16EDGAR2Form 8-K - Current report
05/1/202407:00GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
02/1/202415:06EDGAR2Form S-3ASR - Automatic shelf registration statement of..
15/12/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202318:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202316:09EDGAR2Form 144 - Report of proposed sale of securities
13/12/202320:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202320:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202315:53EDGAR2Form 144 - Report of proposed sale of securities
13/12/202315:46EDGAR2Form 144 - Report of proposed sale of securities
12/12/202317:17EDGAR2Form 144 - Report of proposed sale of securities
11/12/202318:05EDGAR2Form 144 - Report of proposed sale of securities
04/12/202319:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202319:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202319:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202320:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202320:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202320:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202315:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
07/11/202307:00GLOBESoleno Therapeutics Provides Corporate Update and Reports..
06/11/202307:00GLOBESoleno Therapeutics Announces Peer-Reviewed Publication of..
31/10/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
20/10/202315:32EDGAR2Form S-3 - Registration statement under Securities Act of..
16/10/202315:30EDGAR2Form SC 13D/A - General statement of acquisition of..
12/10/202315:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/10/202315:30EDGAR2Form SC 13D/A - General statement of acquisition of..
10/10/202315:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/10/202317:16GLOBECorrecting & Replacing -- Soleno Therapeutics Announces DCCR..
04/10/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202315:05GLOBESoleno Therapeutics Announces DCCR Data Presentation at the..

Su Consulta Reciente

NASDAQ
SLNO
Soleno Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados